Correspondence 0001213900-23-011611 from INTENSITY THERAPEUTICS, INC. (INTS)

INTENSITY THERAPEUTICS, INC.
Date: Feb. 14, 2023 · CIK: 0001567264 · Accession: 0001213900-23-011611

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-260565

Date

February 14, 2023

Author

Not clearly detected

Form

CORRESP

Company

INTENSITY THERAPEUTICS, INC.

Letter

Intensity Therapeutics, Inc.

61 Wilton Road, 3rd Floor

Westport, CT 068809

February 14, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

RE: Intensity Therapeutics, Inc. (CIK 0001567264)

Registration Statement No. 333-260565 on Form S-1 (the “Registration Statement”)

Ladies and Gentlemen:

Intensity Therapeutics, Inc. (the “Registrant”) hereby withdraws its request submitted on February 9, 2023 for acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), for February 13, 2023 at 4:30 p.m., Eastern Time.

The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, McDermott Will & Emery LLP, by calling Daniel L. Woodard at (212) 547-5553. The Company hereby authorizes Mr. Woodard to orally modify or withdraw this request for acceleration.

Very truly yours,
INTENSITY THERAPEUTICS, INC.

Show Raw Text

CORRESP
1
filename1.htm

Intensity Therapeutics, Inc.

61 Wilton Road, 3rd Floor

Westport, CT 068809

February 14, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

    RE:
    Intensity Therapeutics, Inc. (CIK 0001567264)

    Registration Statement No. 333-260565 on Form S-1 (the “Registration Statement”)

Ladies and Gentlemen:

Intensity Therapeutics, Inc.
(the “Registrant”) hereby withdraws its request submitted on February 9, 2023 for acceleration of the effectiveness
of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities
Act”), for February 13, 2023 at 4:30 p.m., Eastern Time.

The undersigned respectfully
requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, McDermott Will &
Emery LLP, by calling Daniel L. Woodard at (212) 547-5553. The Company hereby authorizes Mr. Woodard to orally modify or withdraw this
request for acceleration.

    Very truly yours,

    INTENSITY THERAPEUTICS, INC.

    By:
    /s/ Lewis H. Bender

    Lewis H. Bender

    Chief Executive Officer

SecProbe.io